Biotech · Private company
HanAll BioPharma Co., Ltd.
Track this companyFree. Adds HanAll BioPharma Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- 0.25% Tanfanercept Ophthalmic SolutionPhase 3 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
- HL036 Ophthalmic SolutionPhase 3 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
- tanfanerceptPhase 3 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 3 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
- HL-009 Liposomal GelPhase 2 · Mild to Moderate Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- Peginterferon alfa-2aPhase 2 · Chronic Hepatitis C InfectionClinicalTrials.gov · fetched Nov 12, 2026
- recombinant variant of interferon-alpha 2bPhase 2 · Chronic Hepatitis C InfectionClinicalTrials.gov · fetched Nov 12, 2026
- RibavirinPhase 2 · Chronic Hepatitis C InfectionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Study to Evaluate the Efficacy and Safety of Tanfanercept (HL036) in Dry Eye DiseasePHASE3 · SUSPENDED · started May 1, 2024ClinicalTrials.gov NCT06400589 · fetched Nov 12, 2026
- A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry EyePHASE3 · COMPLETED · started Nov 18, 2021ClinicalTrials.gov NCT05109702 · fetched Nov 12, 2026
- A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry EyesPHASE3 · COMPLETED · started Mar 10, 2019ClinicalTrials.gov NCT03846453 · fetched Nov 12, 2026
- A Study to Assess Efficacy of HL036 in Subjects With Dry EyesPHASE2 · COMPLETED · started Nov 5, 2017ClinicalTrials.gov NCT03334539 · fetched Nov 12, 2026
- Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic DermatitisPHASE2 · COMPLETED · started Apr 9, 2012ClinicalTrials.gov NCT01568489 · fetched Nov 12, 2026
- A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis CPHASE1_PHASE2 · COMPLETED · started Jun 23, 2011ClinicalTrials.gov NCT01194037 · fetched Nov 12, 2026